title: Successful photodynamic therapy with verteporfin for recurrent choroidal neovascularization beneath the new fovea after macular translocation surgery with 360-degree retinotomy.
abstract: OBJECTIVE
  To report a case of successfully treated recurrent choroidal neovascularization after macular translocation surgery with 360-degree retinotomy by photodynamic therapy with verteporfin.
  
  
  METHODS
  Interventional case report.
  
  
  METHODS
  A 76-year-old man developed recurrent choroidal neovascularization at the new fovea after macular translocation surgery with 360-degree retinotomy.
  
  
  RESULTS
  Two sessions of photodynamic therapy were applied, which resolved the choroidal neovascularization. Best-corrected visual acuity improved to 20/50 at the 6 and 12 months follow-up.
  
  
  CONCLUSIONS
  Photodynamic therapy may be an option for treatment of recurrent choroidal neovascularization in the new subfoveal region after macular translocation surgery with 360-degree retinotomy.
authors.affiliation: Department of Ophthalmology and Science, Osaka University Medical School, Suita, Osaka, Japan. sawamiki@ophthal.med.osaka-u.ac
authors.forename: Miki
authors.initials: M
authors.lastname: Sawa
authors.forename: Wai-Man
authors.initials: WM
authors.lastname: Chan
authors.forename: Masahito
authors.initials: M
authors.lastname: Ohji
authors.forename: Kazuyuki
authors.initials: K
authors.lastname: Imai
authors.forename: Takashi
authors.initials: T
authors.lastname: Fujikado
authors.forename: Yasuo
authors.initials: Y
authors.lastname: Tano
authors.forename: Andrew P
authors.initials: AP
authors.lastname: Schachat
mesh_terms: D000368:Aged; D015862:Choroid Diseases / Q000150:complications; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology; D005451:Fluorescein Angiography; D005584:Fovea Centralis; D006801:Humans; D007208:Indocyanine Green; D008266:Macula Lutea / Q000637:transplantation*; D008297:Male; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use*; D011166:Porphyrins / Q000627:therapeutic use*; D011183:Postoperative Complications; D012008:Recurrence; D012166:Retinal Hemorrhage / Q000209:etiology / Q000601:surgery; D000077362:Verteporfin
chemical_list: D017319:Photosensitizing Agents; D011166:Porphyrins; D000077362:Verteporfin; D007208:Indocyanine Green